CANADA LIFE ASSURANCE Co Has $125.67 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

CANADA LIFE ASSURANCE Co lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 240,895 shares of the medical equipment provider’s stock after buying an additional 1,953 shares during the quarter. CANADA LIFE ASSURANCE Co owned about 0.07% of Intuitive Surgical worth $125,669,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new position in Intuitive Surgical during the 4th quarter worth $25,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Hurley Capital LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Summit Securities Group LLC bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ISRG. Erste Group Bank cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Citigroup increased their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. CICC Research started coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Finally, Barclays raised their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $611.81.

Intuitive Surgical Price Performance

ISRG stock opened at $481.34 on Thursday. The stock has a market cap of $171.44 billion, a price-to-earnings ratio of 75.09, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The company has a fifty day moving average price of $526.67 and a two-hundred day moving average price of $532.10. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 in the last three months. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.